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infectious or infl ammatory states, where deposits are 
smaller and are less likely to produce myocardial dysfunc-
tion. Familial amyloidosis is an autosomal dominant form, 
which results from deposition of form of prealbumin, 
transthyretin, and approximately one quarter of patients 
with transthyretin-induced familial amyloidosis have car-
diac involvement, marked often by conduction system in-
volvement. Primary amyloidosis affects 4.5 of 100,000 
individuals7,8. It often occurs in patients over the age of 40, 
and the median survival of individuals with primary 
amyloidosis who present with heart failure is six months7.
Case report
A 52-year-old woman presented to her physician with 
a history of fatigue. The diagnosis was hypothyroidism 
because patient had a total thyroidectomy two years prior, 
Primary light-chain (AL) amyloidosis is a plasma cell 
dyscrasia associated with the deposition of immunoglobu-
lin-derived amyloid in multiple organs. In the heart, this 
results in an infi ltrative cardiomyopathy, with increased 
left ventricular wall thickness, normal or decreased LV 
cavity size and congestive heart failure. Cardiac involve-
ment is a major determinant of prognosis of AL amyloido-
sis1,2. In vast majority of cases, the excess production of 
this protein results from a monoclonal expansion of plas-
ma cells in multiple myeloma, and rarely, a patient with a 
plasma cell dyscrasia may develop restrictive cardiomy-
opathy due to deposition of light chains in a nonamyloid 
manner which seems may be reversible. Three types of 
amyloidosis that can affect the heart are primary amyloi-
dosis (also known as immunoglobulin light chain amyloi-
dosis), senile systemic amyloidosis, and familial amyloido-
sis. Secondary amyloidosis may result from chronic 
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A B S T R A C T
Primary light-chain (AL) amyloidosis is a plasma cell dyscrasia associated with the deposition of immunoglobulin-
derived amyloid in multiple organs. In the heart, this results in an infi ltrative cardiomyopathy, with increased left ven-
tricular wall thickness, normal or decreased left ventricular (LV) cavity size and congestive heart failure. Cardiac involve-
ment is a major determinant of prognosis of AL amyloidosis. We report a patient with cardiac amyloidosis proven by 
cardiac biopsy, and aim to point out at transthoracic echocardiography as the hallmark of diagnostics. Echocardiography 
revealed increased LV thickness at 20mm, impaired LV ejection fraction (EF) at 35%, enlarged atria, transmitral decel-
eration time at 156 ms and increased E/A ratio at 4.25. Early diagnosis and intervention can have a signifi cant impact 
on the patient’s response to treatment, especially when the underlying condition involves a malignancy or infi ltrative 
disorder. Standard transthoracic echocardiography as a noninvasive diagnostic tool is valuable and has a signifi cant 
role in diagnosis and prognosis.
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and was taking substitute hormonal therapy. A year after, 
because of mild elevated blood pressure she was given 
ACE inhibitor and beta-blocker in small doses (cilazapril 
and bisoprolol). After a year she presented to her family 
physician with a few month history of progressive short-
ness of breath. At the time of this visit she was able to 
perform her daily activities, however, she said that her 
exercise tolerance was affected mainly by fatigue. The 
patient was referred to cardiologist. An echocardiogram 
revealed impaired left ventricular systolic function, severe 
diastolic dysfunction, ventricular wall thickness with 
small intracavitary chambers, enlarged atria and mild 
mitral and tricuspid regurgitation. The wall of ventricle 
was sparkling and granular texture (Figure 1). Echocar-
diography showed an increased mean left ventricular wall 
thickness (MVT) of 20 mm and an impaired ejection frac-
tion (EF) of 35% on two-dimensional echocardiography. 
The deceleration time (DT) of 156 ms and increased early 
diastolic fi lling velocity-to-atrial fi lling velocity transmi-
tral (E/A) ratio of 4.25 (Figure 2).
The echocardiographic appearance of thickened ven-
tricle accompanied with low QRS voltage in EKG was 
characteristic (Figure 3).
Clinically, the patient was normotensive, had a mild 
systolic murmur (caused by mitral regurgitation), had no 
hepatomegaly or pedal edema, chest x-ray showed en-
larged heart, and she reported no paroxysmal nocturnal 
dyspnea and orthopnea.
As there was a marked change in her condition, patient 
was admitted to our Clinic for further testing. After ad-
mittance, a series of investigations were performed, in-
cluding transthoracic echocardiography, catheterization 
of the heart, and an endomyocardial biopsy. The pathology 
fi ndings from the endomyocardial biopsy (EMB) demon-
strated features of cardiac amyloidosis, interstitial positiv-
Fig. 1. Non-dilated cardiomyopathy with thickening of the wall 
of ventricle, sparkling and granular texture, LV left ventricle, 
LA left atria, IVS interventricular septum, PW LV posterior wall
Fig. 3. Low voltage on the ECG
Fig. 2. The deceleration time (DT) of 156 ms and increased 
early diastolic fi lling velocity-to-atrial fi lling velocity (E/A) 
ratio of 4.25, E early diastolic transmitral velocity, A late 
diastolic transmitral velocity
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ity for amyloid. Biopsy showed patchy widespread accumu-
lation of material in the interstitium that showed apple 
green birefringence in polarized light and stained posi-
tively with Congo red (Figure 4). These fi ndings are con-
sistent with amyloid protein deposits. Free immunoglobu-
lin kappa light chains in the urine were detected and none 
were fi nd in serum. The patient was diagnosed with re-
strictive infi ltrative cardiomyopathy, cardiac amyloidosis, 
NYHA II- III functional class. Patient was treated with 
low doses of diuretics and had symptomatic benefi t and is 
currently in follow- up. Duration of follow-up in this pa-
tient is one year.
Discussion
Cardiac amyloidosis is characterized as a »stiff heart« 
syndrome with impairment of diastolic function secondary 
to amyloid infi ltration of the myocardium. Early recogni-
tion may improve the poor prognosis of these individuals. 
Cardiac amyloidosis should be considered when the pa-
tient presents with rapidly progressing dyspnea, a non-
dilated cardiomyopathy with thickening of the LV wall on 
echocardiogram, and low voltage ECG with or without a 
pattern that resembles a myocardial infarction.
Primary amyloidosis results from an accumulation of 
immunoglobulin light chains due to a clonal B cell disor-
der such as multiple myeloma. Patients with primary 
amyloidosis, with heart involvement, progress rapidly and 
have a median survival of six months once heart failure 
develops. For senile amyloidosis, the median survival is 
fi ve years once heart failure develops9. The signs and 
symptoms of congestive heart failure can be recognized 
easily. However, establishing the underlying cause can be 
more diffi cult.
We report a patient with cardiac amyloidosis, and aim 
to point out at transthoracic echocardiography as the hall-
mark of diagnostics. Cardiac amyloidosis is characterized 
with impairment of diastolic function secondary to amy-
loid infi ltration of the myocardium2. Filling patterns are 
closely related to the degree of am yloid infi ltration, as 
measured by mean left ventricular wall thickness2,4,8. 
Early cardiac amyloidosis (with a mildly increased mean 
wall thickness of more than 12 but less than 15 mm) shows 
an abnormal relaxation pattern characterized by a de-
creased early fi lling velocity-to-atrial fi lling velocity ratio 
(E/A ratio), a normal-to-prolonged deceleration time, and 
a prolonged isovolumic relaxation time. Advanced cardiac 
amyloidosis (markedly increased mean wall thickness of 
15 mm or more) shows a short deceleration time and an 
increasing E/A ratio, which are consistent with restrictive 
type of diastolic dysfunction4.
The combination of the doppler variables of shortened 
deceleration time and increased early diastolic fi lling ve-
locity to atrial fi lling velocity ratio and NYHA functional 
class are stronger predictors of cardiac death than are the 
two-dimensional echocardiographic variables of mean left 
ventricular wall thickness and fractional shortening4. 
This emphasizes that an increased transmitral E/A ratio 
and a short deceleration time, which are markers of re-
strictive physiology, are associated with poor outcome in 
patients with cardiac amyloidosis, because the Doppler 
factors are more direct measures of hemodynamic func-
tion than mean left ventricular wall thickness, which is 
an indirect measure of impaired diastolic function. Our 
patient has advanced cardiac amyloidosis with echocar-
diographic fi ndings of short deceleration time and an in-
creasing transmitral E/A ratio, which are consistent with 
restrictive type of diastolic dysfunction.
The use of doppler variables adds independent value to 
the estimation of prognosis in patients with cardiac amy-
loidosis. Patients with mildly increased wall thickness 
may still have restrictive type of diastolic dysfunction, 
which suggests a poorer outcome than that predicted by 
the measurement of the wall thickness alone. Multiple 
factors can infl uence left ventricular diastolic fi lling vari-
ables, including the aging process, loading conditions, 
heart rate, and valvular regurgitation. Patients with re-
strictive type of diastolic dysfunction have worse cardiac 
prognosis, they may be earlier candidates for transplanta-
tion.
Multivariate survival analysis identifi ed independent 
predictors of clinical outcome in patients with AL amyloi-
dosis, New York Heart Association class III or IV, presence 
of pleural effusion, brain natriuretic peptide level >493 pg/
mL, ejection time <273 ms, and peak longitudinal sys-
tolic basal anteroseptal strain less negative than or equal 
to −7.5% defi ned a high-risk group of patients5. In patients 
with endomyocardial biopsy (EMB)-documented cardiac 
amyloidosis, longer-term survival is more strongly associ-
ated with New York Heart Association functional class 
compared with electrocardiographic and echocardiograph-
ic variables6. Our patient, who was at the time of diagno-
sis in NYHA II–III functional class, although she had 
markedly increased mean wall thickness and restrictive 
type of diastolic dysfunction is in follow up of one year 
doing well.
Fig. 4. With Congo red stain, amyloid appears salmon-coloured 
in ordinary light but shows apple green birefringence in 
polarized light.
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In contrast to standard echocardiography, strain and 
strain rate are able to demonstrate that signifi cant differ-
ences in systolic function occur as cardiac amyloid infi ltra-
tion progresses to congestive heart failure. Tissue velocity, 
although a little better than standard 2D echocardiogra-
phy for the detection of functional abnormalities, was not 
as good as strain/SR. Standard doppler echocardiography 
measures velocities of blood fl ow and is well established 
for the assessment of hemodynamics and for detecting 
global abnormalities of diastolic function7.
The treatment of AL amyloidosis with high-dose intra-
venous melphalan and autologous stem cell transplant is 
a new and effective therapy for AL amyloidosis, although 
it is best tolerated in patients without severe heart dis-
ease. If effective, as defi ned by a hematologic response, 
cardiac function assessed by standard echocardiography 
usually stabilizes, but regression of echocardiographic 
evidence of heart disease is not usually apparent despite 
clinical improvement in congestive heart failure. Strain 
and strain rate are sensitive methods for assessing car-
diac function and may possibly detect changes in cardiac 
function after chemotherapy. Evaluation of patients with 
these modalities at the time of presentation may help to 
determine selection of patients for aggressive chemother-
apy7.
Primary amyloidosis with cardiac symptoms is a dev-
astating disease where symptoms progress rapidly, and 
patients often only live for months. While the prognosis 
remains poor, early recognition of the underlying cause of 
heart failure of unknown origin will facilitate manage-
ment of a patient with cardiac amyloidosis and aid in at-
tempts to improve the outcome of the patient8. Thus, many 
patients were diagnosed as having cardiac amyloidosis 
without endomyocardial biopsy. Endomycardial biopsy is 
a safe and reliable procedure for diagnosing cardiac amy-
loidosis, and immunohistochemical staining of routinely 
processed biopsy specimens can be performed to classify 
the type of amyloid present. However, on the basis of au-
topsy studies, it generally is accepted that the fi nding of 
LV thickening by echocardiography in the absence of dis-
eases associated with LV hypertrophy is highly specifi c for 
the fi nding of cardiac amyloid deposition at biopsy or au-
topsy8. A low voltage on the ECG and increased septal and 
posterior LV wall thickness on the echocardiogram are 
highly specifi c for cardiac amyloidosis in the setting of 
biopsy-proven systemic amyloidosis10. In older patients 
without serum or urinary light chains, immunohisto-
chemical staining is recommended to distinguish AL from 
AS types of amyloid in cardiac biopsy tissues10. Determi-
nation of the underlying cause of heart failure is essential 
as it will infl uence the management of the patient.
Conclusion
Standard echocardiography as a noninvasive diagnos-
tic tool is valuable and has a signifi cant role in diagnosis 
and prognosis of cardiac amyloidosis. Cardiac amyloidosis 
is characterized by increased left ventricular wall thick-
ness, normal or decreased LV cavity size, and congestive 
heart failure with normal or near-normal fractional short-
ening, a marked increase in wall thickness, reduced LV 
systolic function, shortened deceleration time, and in-
creased early diastolic fi lling velocity to atrial fi lling ratio 
as restrictive type of diastolic dysfunction, wall of ven-
tricle is sparkling and granular texture. Myocardial biop-
sies must be performed for a defi nitive diagnosis to be 
made. Early intervention can have a signifi cant impact on 
the patient’s response to treatment, especially when the 
underlying condition involves a malignancy or infi ltrative 
disorder therefore transthoracic echocardiography as a 
noninvasive diagnostic tool is valuable, and has a signifi -
cant role in diagnosis and prognosis.
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ULOGA STANDARDNE EHOKARDIOGRAFIJE U AMILOIDOZI SRCA DOKAZANOJ BIOPSIJOM 
MIOKARDA
S A Ž E T A K
Primarna amiloidoza je diskrazija plazma stanica sa depozitima amiloida u multiplim organima. U srcu, to rezul-
tira infi ltrativnom kardiomiopatijom, zadebljalih stijenki ventrikla, normalnim ili smanjenim šupljinama srca te za-
tajenjem srca. Zahvaćenost srca je najvažniji prognostički faktor amiloidoze. Prikazujemo pacijenticu u dobi od 52 godine 
sa biopsijom miokarda dokazanom amiloidozom srca, u cilju prepoznavanja važnosti i naglašavanja ehokardiografskih 
karakteristika amiloidoze srca te ehokardiografi je kao temeljnog dijagnostičkog postupka. Amiloidozu srca karakterizira 
dijastolička disfunkcija zbog infi ltracije miokarda amiloidom. Rano prepoznavanje može poboljšati prognozu bolesnika. 
Na amiloidozu srca treba posumnjati kod bolesnika sa progresivnom dispnejom, uz nedilatativnu kardiomiopatiju sa 
zadebljalim stijenkama ventrikla u ehokardiogramu te zabilježenom mikrovoltažom u EKG-u. Pravovremena dijagnoza 
ima odraza na bolesnikov odgovor na liječenje, osobito ako osnovno stanje uključuju malignitet ili infi ltrativni poremećaj, 
stoga standardna transtorakalna ehokardiografi ja kao neinvaziva dijagnostička metoda ima značajnu ulogu u 
dijagnostičkom postupku i prognozi bolest.
